Editas Medicine (EDIT) Reports Q1 Loss of $0.60
Tweet
Share
E-mailGet Alerts EDIT Hot Sheet
Join SI Premium – FREE
Editas Medicine (NASDAQ: EDIT) reported Q1 EPS of ($0.60), versus $0.67 reported last year. Revenue for the quarter came in at $2.07 million, versus $3.93 million reported last year.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Micron Technology (MU) PT Raised to $1,550 at Needham
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
